Hemodialysis, the most common modality of renal replacement therapy, is critically required
to remove uremic toxins from the blood of patients with end-stage kidney disease. However …

Hemodialysis is the prevailing approach in renal replacement therapy, critically required for
eliminating uremic toxins from the blood of individuals suffering from end-stage renal …

Uremic toxins (UTs), particularly protein-bound uremic toxins (PBUTs), accumulate in
chronic kidney disease (CKD) patients, causing significant health complications like uremic …

The development of hemodialysis (HD) membranes has substantially advanced in the last
decade. This has resulted in the manufacturing of medium cut-off membranes (MCO) whose …

Introduction Uremic toxicity changes the gut structure and permeability, allowing bacterial
toxins to translocate from the lumen to the blood during chronic kidney failure (CKD). Clinical …

It has been reported that survival on mild hypoalbuminemia due to high albumin leakage did
not worsen in patients on hemodialysis (HD) or online hemodiafiltration (OHDF) even …

中截留量膜是近年来血液透析领域的一项重要研究进展, 相比高通量透析膜可显著提高对较大的
中分子尿毒症毒素的清除. 目前越来越多的临床研究证实其良好的安全性, 显著的短期临床疗效 …

ORCID: https://orcid. org/0000-0002-6695-7062 as high-volume HDF in the removal of
protein-binding compounds and middle molecules, MCO-HD is expected to show survival …

Abstract Background and Aims Medium cut-off membranes (MCO) have been introduced
with the claim that larger pores enhance the removal of middle-sized uremic toxins. To date …

Correction: Kim et al. The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic
Toxins. Toxins 2022, 14, 779 Page 1 Citation: Kim, YG; Lee, SH; Jung, SW; Jung, GT; Lim, HJ; …